Physician

Ambreen Ashraf, MD

According to 2025 Medicare claims, Ambreen Ashraf, MD (NPI: 1861656746) practices rheumatology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is ARTHRITIS AND AUTOIMMUNITY CLINIC PLLC (NPI: 1548939143; TIN: 863679923) and primary practice location at 48187-9998.

Ashraf's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 42 traditional Medicare patients, billed 206 HCPCS/CPT codes, and received $9,618 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 981 prescription claims across 103 beneficiaries totaling $616,351 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 2 records totaling $107. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $18,648 to $9,618. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $97,477 and ending at $616,351. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$9.3K$19K2015 Medicare payment: $18,648 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $12,142 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $10,850 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $11,275 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,067 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $7,617 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $9,618 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201590257$18,648
201672183$12,142
201763159$10,850
201857163$11,275
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222149$4,067
202334173$7,617
202442206$9,618

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$308K$616K2015 Drug cost: $97,477 (USD; Tot_Drug_Cst)2016 Drug cost: $114,641 (USD; Tot_Drug_Cst)2017 Drug cost: $405,402 (USD; Tot_Drug_Cst)2018 Drug cost: $509,497 (USD; Tot_Drug_Cst)2019 Drug cost: $178,317 (USD; Tot_Drug_Cst)2022 Drug cost: $28,925 (USD; Tot_Drug_Cst)2023 Drug cost: $214,210 (USD; Tot_Drug_Cst)2024 Drug cost: $616,351 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201587480$97,477
201686652$114,641
201789745$405,402
201899961$509,497
201961403$178,317
2020N/RN/RN/R
2021N/RN/RN/R
202224116$28,925
202363480$214,210
2024103981$616,351

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more2020$121
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2239$90

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab28784$196,293
RinvoqUpadacitinib13390$94,989
Humira PenAdalimumab13364$87,475
MethotrexateMethotrexate Sodium1296,211$3,636
LeflunomideLeflunomide432,660$2,673

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$107Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ambreen Ashraf, MD?

Tedicare shows public-source Medicare data for Ambreen Ashraf, MD (NPI 1861656746), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ambreen Ashraf, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ambreen Ashraf, MD?

Ambreen Ashraf, MD is linked to ARTHRITIS AND AUTOIMMUNITY CLINIC PLLC (billing NPI 1548939143) in the available physician profile data.

Does Ambreen Ashraf, MD have Open Payments data?

Ambreen Ashraf, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.